Director, Commercial Data, Advanced Analytics & Forecasting

Since our founding in 2009, REGENXBIO has pioneered what's possible in gene therapy. Today, we are advancing a pipeline of gene therapies designed to improve the lives of patients facing serious rare and retinal diseases and preparing to bring innovative new medicines to patients.

Our work is fueled by purpose and urgency because every day matters to patients and their families. If you're looking for meaningful work, opportunities to grow, and the chance to help bring potentially transformative gene therapies to patients, we'd love to hear from you.

What we do matters.

Gene therapy company advancing NAV AAV vector platform for diseases in neuroscience, metabolic, and ophthalmology. Based in Rockville, MD.

regenxbio.com